{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:43:03Z","timestamp":1757702583965},"reference-count":25,"publisher":"Japanese Society of Hypertension","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2007]]},"DOI":"10.1291\/hypres.30.635","type":"journal-article","created":{"date-parts":[[2007,9,3]],"date-time":"2007-09-03T05:53:09Z","timestamp":1188798789000},"page":"635-642","source":"Crossref","is-referenced-by-count":17,"title":["Effects of Renin-Angiotensin System Blockade on Macrophage Infiltration in Patients with Hypertensive Nephrosclerosis"],"prefix":"10.1291","volume":"30","author":[{"given":"Toshihiko","family":"IMAKIIRE","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"KIKUCHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muneharu","family":"YAMADA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taketoshi","family":"KUSHIYAMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keishi","family":"HIGASHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"HYODO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kojiro","family":"YAMAMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"ODA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigenobu","family":"SUZUKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichiro","family":"MIURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"119","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. USRDS: United States Renal Data System 2002 Annual Data Report: incidence and prevalence. Am J Kidney Dis<\/i> 2003; 41<\/b> (Suppl 2): S41-S56.","DOI":"10.1016\/S0272-6386(03)80006-9"},{"key":"2","unstructured":"2. Mann JFE, Hilgers KF, Veelken R, Geiger H, Schmieder RE, Luft FC: Effect of antihypertensive therapy on progression of non-diabetic renal disease. Clin Nephrol<\/i> 1992; 38<\/b>: S74-S77."},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.29.15"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Johnson RJ, Alpers CE, Yoshimura A, et al<\/i>: Renal injury from angiotensin II−mediated hypertension. Hypertension<\/i> 1992; 19<\/b>: 464-474.","DOI":"10.1161\/01.HYP.19.5.464"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00424.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Mezzano S, Droguett A, Burgos ME, et al<\/i>: Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Kidney Int Suppl<\/i> 2003; 86<\/b>: S64-S70.","DOI":"10.1046\/j.1523-1755.64.s86.12.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hilgers KF, Hartner A, Porst M, Veelken R, Mann JFE: Angiotensin II type 1 receptor blockade prevents lethal malignant hypertension. Relation to kidney inflammation. Circulation<\/i> 2001; 104<\/b>: 1436-1440.","DOI":"10.1161\/hc3601.095576"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Lewis EJ, Hunsicker LG, Clarke WR, et al<\/i>: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med<\/i> 2001; 345<\/b>: 851-860.","DOI":"10.1056\/NEJMoa011303"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)10363-X"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hotta O, Yusa N, Ooyama M, Taguma Y: Urinary macrophage counts and ratio to T lymphocytes: possible use in differential diagnosis and management of glomerular disease. J Clin Lab Anal<\/i> 1996; 10<\/b>: 205-208.","DOI":"10.1002\/(SICI)1098-2825(1996)10:4<205::AID-JCLA5>3.0.CO;2-8"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Oda T, Hotta O, Taguma Y, et al<\/i>: Clinicopathological significance of intratubular giant macrophages in progressive glomerulonephritis. Kidney Int<\/i> 1998; 53<\/b>: 1190-1200.","DOI":"10.1046\/j.1523-1755.1998.00886.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Furuta T, Saito T, Ootaka T, et al<\/i>: The role of macrophages in diabetic glomerulosclerosis. Am J Kidney Dis<\/i> 1993; 21<\/b>: 480-485.","DOI":"10.1016\/S0272-6386(12)80393-3"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00269.2003"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1007\/s101570170012"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Gruden G, Setti G, Hayward A, et al<\/i>: Mechanical stretch induces monocyte chemoattractant activity via<\/i> an NF-κB−dependent monocyte chemoattractant protein-1−mediated pathway in human mesangial cells: inhibition by rosiglitazone. J Am Soc Nephrol<\/i> 2005; 16<\/b>: 688-696.","DOI":"10.1681\/ASN.2004030251"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.28.865"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.21.2719"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042167"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.27.21"},{"key":"20","unstructured":"20. Prodjosudjadi W, Gerritsma JS, van Es LA, Daha MR, Bruijn JA: Monocyte chemoattractant protein-1 in normal and diseased human kidneys: an immunohistochemical analysis. Clin Nephrol<\/i> 1995; 44<\/b>: 148-155."},{"issue":"6","key":"21","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1161\/01.HYP.30.6.1397","volume":"30","year":"1997","ISSN":"http:\/\/id.crossref.org\/issn\/0194-911X","issn-type":"print"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Chen XL, Tummala PE, Olbrych MT, Alexander RW, Medford RM: Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res<\/i> 1998; 83<\/b>: 952-959.","DOI":"10.1161\/01.RES.83.9.952"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kim S, Ohta K, Hamaguchi A, et al<\/i>: Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury. Kidney Int<\/i> 1994; 46<\/b>: 1346-1358.","DOI":"10.1038\/ki.1994.404"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kagami S, Border WA, Miller DE, et al<\/i>: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest<\/i> 1994; 93<\/b>: 2431-2437.","DOI":"10.1172\/JCI117251"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Rodrigues-Iturbe B, Johnson RJ: Role of inflammatory cells in the kidney in the induction and maintenance of hypertension. Nephrol Dial Transplant<\/i> 2006; 21<\/b>: 260-263.","DOI":"10.1093\/ndt\/gfi319"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T19:50:00Z","timestamp":1556826600000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nature.com\/doifinder\/10.1291\/hypres.30.635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1291\/hypres.30.635","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007]]}}}